Continuous Biologics Manufacturing for Modular and Sustainable Operations, Upcoming Webinar Hosted by Xtalks

Continuous Biologics Manufacturing for Modular and Sustainable Operations, Upcoming Webinar Hosted by Xtalks ...
GEN

Scaling New Heights in Continuous Biologics Manufacturing with the XCell ATF System

In recent years, fed-batch biomanufacturing has begun giving way to continuous manufacturing processes, as developers face pressure to balance affordability with high manufacturing quality. Although ...
Nasdaq

WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale

SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced today that it has ...
GEN

Process Mass Intensity is Only Partial Gauge of Sustainability for Biologics

If you’re using process mass intensity (PMI) to gauge sustainability of continuous and batch manufacturing processes for biologics, you’re only seeing part of the picture. Recent research shows that ...
Labroots

Panel Presentation: N-GLYcanyzer: An Automated Process Analytical Platform To Enable Continuous Manufacturing Of Biologics

The biopharmaceutical industry is transitioning towards continuous biomanufacturing processes that require advanced analytical tools to monitor and control bioprocesses to produce high-quality ...
KXAN

WuXi Biologics' WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale

Building on its success in developing continuous production at pilot-scale with the WuXiUP™ platform, WuXi Biologics has further enhanced the technology to achieve automated continuous drug substance ...